Marilyn Bui

Professor of Pathology, Moffitt Cancer Center
When
26th-27th May 2021
9 AM EDT (UTC -4:00)
Where
Virtual Conference
This spring the Digital Pathology & AI Congress is being held virtually. The agenda explores the latest developments in applying artificial intelligence and machine learning to primary diagnosis and clinical research and examines the strategies needed to deploy the technology.
The platform we have chosen is designed to facilitate collaboration between the multiple stakeholders who attend this meeting. This will enable you to seamlessly network with key opinion leaders, investigators & researchers.
Watch this video to discover more…
“We have been enjoying the conference, and the platform is amazing.”
“This is by far the best ‘virtual’ event platform I have used”
Professor, Medical Biophysics, University of Toronto
Professor, Department of Pathology, Nagasaki University, Japan
Division Head, Pathology Informatics, Henry Ford Health System
Vice Chair of Diagnostic Technology Innovation, Director of Cytopathology, Director of International Telepathology, UCLA, David Geffen School of Medicine, USA
Professor of Pathology, Moffitt Cancer Center
Associate Professor of Pathology, Director, Computational Pathology, Director, Center for Computational Imaging and Signal Analytics, Northwestern University Feinberg School of Medicine
Assistant Professor, Biomedical Engineering, Ryerson University
Professor of Biomedical Data Science, Radiology and Medicine (Biomedical Informatics) Director of Biomedical Informatics, Stanford Cancer Institute, Stanford University
Professor of Pathology and Medicine, Co-Director of the Division of AI & Computational Pathology, Duke University
Associate Vice Chancellor for Informatics for the Health Sciences; Distinguished University Professor and Chair, Department of Biomedical Informatics; Professor of Pathology, Bioengineering, Clinical/Translational Science and Computing/Information, University of Pittsburgh
Professor Emeritus, Laval University, Québec, Canada
RRF Walter H. Helmerich Professor, Medical Physics and Biomedical Engineering, Investigator, CQCI, LOCI, UW-Madison
Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, MD Anderson
John S Dunn Presidential Distinguished Chair of Biomedical Engineering, Houston Methodist; Professor of Pathology, Laboratory Medicine, Radiology, and Neuroscience, Weill Cornell Medicine
Professor, Medical Biophysics, University of Toronto
Professor, Department of Pathology, Nagasaki University, Japan
Division Head, Pathology Informatics, Henry Ford Health System
Vice Chair of Diagnostic Technology Innovation, Director of Cytopathology, Director of International Telepathology, UCLA, David Geffen School of Medicine, USA
Professor of Pathology, Moffitt Cancer Center
Associate Professor of Pathology, Director, Computational Pathology, Director, Center for Computational Imaging and Signal Analytics, Northwestern University Feinberg School of Medicine
Assistant Professor, Biomedical Engineering, Ryerson University
Professor of Biomedical Data Science, Radiology and Medicine (Biomedical Informatics) Director of Biomedical Informatics, Stanford Cancer Institute, Stanford University
Professor of Pathology and Medicine, Co-Director of the Division of AI & Computational Pathology, Duke University
Associate Vice Chancellor for Informatics for the Health Sciences; Distinguished University Professor and Chair, Department of Biomedical Informatics; Professor of Pathology, Bioengineering, Clinical/Translational Science and Computing/Information, University of Pittsburgh
Professor Emeritus, Laval University, Québec, Canada
RRF Walter H. Helmerich Professor, Medical Physics and Biomedical Engineering, Investigator, CQCI, LOCI, UW-Madison
Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, MD Anderson
John S Dunn Presidential Distinguished Chair of Biomedical Engineering, Houston Methodist; Professor of Pathology, Laboratory Medicine, Radiology, and Neuroscience, Weill Cornell Medicine
“I very much enjoyed the keynote presentations. The content was relevant and informative”
“A well-balanced mix of pathologists and computer scientists”
“The pairing of the two subjects – AI and digital pathology was the best part of the conference”
This pre-event webinar is hosted by Aiforia. It is free to attend and separately bookable. The final guest list is subject to approval.
Track hop and access over 60 presentations
Give a poster presentation
Join networking discussion rooms
Access the virtual exhibition room
Priority networking with other attendees
Create post-event connections
Conference workbook
Presentations will be available on-demand shortly after the meeting
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
You can book securely inside the virtual event platform to get your login details
instantly.
To pay by invoice, please contact [email protected]
Standard rate ** | $299 |
Solution Provider rate + | $899 |
Group booking: 3 Passes ** | $750 |
Group booking: 5 Passes ** | $1100 |
Group booking: 10 Passes ** | $1900 |
** For pharma, biotech, academic institutions, hospitals and not for profit organisations
+ Representatives of organisations offering services and/or business & technology solutions and also to business consultants. Access all networking features.
Don’t forget the separately bookable webinar taking place on 25 May.
Organisations offering services and/or business & technology solutions and business consultants please contact Gavin Hambrook or Nick Best to discuss participation at this meeting
Dell Technologies provides transformative solutions that help healthcare-life sciences organizations prepare for the road ahead as they accelerate their digital strategies – from the point of care to the core to the cloud. From the world’s leading healthcare systems to rural health clinics, we offer essential infrastructure solutions for Modernized Technology, Connected Workforce, Virtual Health, Personalized Health and Secure Care to help you achieve business and clinical agility.
https://www.delltechnologies.com/en-us/solutions/healthcare-and-life-sciences.htm#tab0=3
Corista’s DP3 is unlocking the scale, reach and utility of digital pathology, worldwide. The only digital pathology software natively reading every scanner’s image format, DP3 integrates universal image access, complete workflow, collaboration, and search and analysis functionality. DP3 integrates with any LIS, and is accessible from any web-enabled device. DP3 was awarded Frost & Sullivan’s Product Innovation Award in 2014.
×Corista delivers the leading array of integrated workflow, analytical and collaborative tools for pathology. Medical centers and bio-pharmaceuticals can collaborate, communicate, teach and report with access to image analytics. Pathologists and scientists easily manage their cases, conduct digital consults and have R&D platforms for application of their algorithms. Corista provides a new level of interoperability integrating the patient’s clinical data with WSI and gross images along with access to “best of breed” analytic tools.
×NanoString®is a leading provider of life sciencetools for translational research and diagnostics. Citedin over 2,500 peer-reviewed publications, the nCounter®Analysis System measuresgene and protein expression to profile novel biomarkers. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections
×Akoya Biosciences, ‘The Spatial Biology Company®’, develops powerful imaging tools to enable researchers gain a better understanding of complex diseases. The company offers the most comprehensive end-to-end solution for high-parameter tissue analysis from discovery through clinical and translational research, enabling more precise therapies for immunooncology and other applications. Akoya’s CODEX platform enables assessment of 40+ biomarkers per slide. The Phenoptics platform provides the assay robustness and throughput necessary for translational and clinical research.
×Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, lower barriers to digital adoption, minimize IT burden and costs — while ensuring patient safety and data privacy. Paige’s products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA breakthrough designation for computational pathology products.
×Lead the change with digital pathology.
More productivity and 100% digital case sign-out is possible today with the Philips IntelliSite Pathology Solution for routine histopathology diagnosis.
Philips IntelliSite Pathology Solution has in vitro diagnostic device status in Europe, Middle East and Asia and is the first digital pathology solution available in the United States and Japan. Philips has already supported several laboratories in making a shift to a 100% digital pathology workflow.
We can help you throughout your digital pathology transformation journey with the aim to empower decision-making and precision diagnostics.
http://www.philips.com/digitalpathology
×Inspirata’s comprehensive cancer informatics solutions bring together disparate data throughout the entire cancer care journey to drive informed decisions that improve survivorship. We’ve assembled the most advanced and proven technologies to help you address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring you the broadest oncology informatics platform available today.
×HistoWiz offers an end-to-end platform for anyone doing histopathology in academia and pharma. This online platform provides industry-leading turnaround time for histology, the largest preclinical pathology database, and a novel pathologist network for on-demand diagnoses.
Our mission is to find cures for life-threatening diseases collaboratively by connecting scientists, pathologists and patients for online collaboration. Through automation and AI, HistoWiz aims to become the global leader in histopathology to accelerate cancer research and drug discovery.
×Aurora mScope is a global leader in developing and implementing digital pathology image management software solutions. Our systems, which are developed by pathologists, are secure, HIPPA compliant, web-based, and scanner agnostic, allowing for easy image access, and intuitive viewing and reporting on smart phones, tablets, and computers anywhere, anytime. Over the last several years, Aurora has installed some of the largest integrated telepathology solutions that are operational in North America and Europe.
http://www.aurorainteractive.com
×Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue’s InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. With the ability to run a same-slide fluorescent and H&E stain, Ultivue’s technology is enabling pathologists to connect traditional morphological analysis with multiplexed immunofluorescent data for comprehensive single-cell phenotyping.
×Deep Bio aims to empower pathologists and streamline their clinical workflows with AI cancer diagnostic software.
Our software, DeepDx analyzes digitized images of patient biopsies, to detect and grade cancer
Our first solution focuses on Prostate cancer, and based on the Gleason Grading System, it provides percentages of each Gleason pattern and total tumor area in seconds.
It is the leading solution providing these quantification metrics and gland-level segmentation.
Click for more info!
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets.
×I liked the program and the speakers. The length of the talks and amount of material was perfect. I liked the mix of biotech, company and academic speakers. I also liked the collegial and friendly atmosphere during the meeting.
There was a wide range of speakers, perfect amount of time per topic and good mix of short and long sessions. The speakers were engaging and truly spoke to audience across pretty diverse fields.
There was varying lecture content – a mixture of technical and research, and the inclusion of a FDA spokesperson to clarify some of the issues.
I liked the mix of image scientists, pathologists and companies. It was an excellent opportunity to meet a diverse group in digital pathology.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience
Market to our event database and/or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas. The booth allows you to provide a pre-recorded video or deliver a live video session to your visitors and capture emails when people register their interest. Live chat with your visitors in discussion groups or 1:1
Options include:
For further details please contact
Nick Best/Gavin Hambrook
Telephone +44 (0) 1865 849841 or
email [email protected]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.